Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); drug benefits; appropriate level of care provisions--Department of Defense. Final rule.
This final rule amends the DoD Regulation 6010.8-R (32 CFR part 199) by: (1) Establishing the absolute requirement for approval by the Food and Drug Administration (FDA) of all prescription drugs and medicines (drugs grandfathered by the Federal Food, Drug and Cosmetic Act of 1938 may be covered under CHAMPUS as if FDA approved); (2) clarifying that medical care related to the use of Group C drugs (approved and distributed by the National Cancer Institute) and Treatment Investigational New Drugs (INDs) will not automatically be considered as experimental when the patient's medical condition warrants the use of these drugs; and (3) reclarifying a CHAMPUS provision that allows benefits in an acute facility above the appropriate level of care. The above changes are reasonable and necessary for effective and uniform administration of CHAMPUS.
D015507:Drugs, Investigational / Q000191:economics; D006077:Government Agencies; D006264:Health Benefit Plans, Employee / Q000331:legislation & jurisprudence*; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence*; D008887:Military Medicine / Q000191:economics*; D011306:Prescription Fees / Q000331:legislation & jurisprudence; D012051:Reimbursement Mechanisms / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational